Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/07/2008WO2008092292A1 Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2
08/07/2008WO2008092267A1 Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
08/07/2008WO2008092262A1 Methods and compounds for treatment, prevention and diagnosis of parasitic infection and disease
08/07/2008WO2008092257A1 Use of catecholamines and related compounds as anti-angiogenic agents
08/07/2008WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases
08/07/2008WO2008092219A2 Pharmaceutical composition comprising tramadol and ketoprofen
08/07/2008WO2008092199A1 Thiopyrimidine-based compounds and uses thereof
08/07/2008WO2008077064A3 Biomarker identifying the reactivation of stat3 after src inhibition
08/07/2008WO2008076918A9 Anti-cancer agents and androgen inhibition activity compound
08/07/2008WO2008076806A9 Compositions and methods to potentiate colistin activity
08/07/2008WO2008076261A3 Water-soluble phenicol prodrugs in a lipophilic vehicle system
08/07/2008WO2008076225A3 Non-nucleoside reverse transcriptase inhibitors
08/07/2008WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
08/07/2008WO2008074267A3 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing
08/07/2008WO2008073479A3 Anticonnexin polynucleotides as impaired wound healing compositions
08/07/2008WO2008073304A3 Cancer treatment methods
08/07/2008WO2008072079A3 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
08/07/2008WO2008072077A3 Combination of 1-aryl-4-cyclopropylpyrazoles with anthelmintic agent for parasitic infestation
08/07/2008WO2008070728A3 Treatment for dry eye using testosterone and progestagen
08/07/2008WO2008070277A3 Methods for treating disruptive behavior disorders
08/07/2008WO2008069960A3 Separable solid dosage form administration system
08/07/2008WO2008067387A3 Estrogen/ serm and estrogen/ progestin bi-layer tablets
08/07/2008WO2008067288A3 Methods for inhibiting foreign body response to implanted materials
08/07/2008WO2008067280A3 Combination of iap inhibitors and flt3 inhibitors
08/07/2008WO2008065527A3 Gallic acid esters of fragrant alcohols
08/07/2008WO2008064018A8 Thienopyrimidinones for treatment of inflammatory disorders and cancers
08/07/2008WO2008063772A9 Resolvin d series and protectin d1 mitigate acute kidney injury
08/07/2008WO2008063287A3 Novel imidazothiazoles and imidazoxazoles
08/07/2008WO2008062428A3 Novel antimicrobial formulations incorporating alkyl esters of fatty acids and nanoemulsions thereof
08/07/2008WO2008061792A3 Tricarbonyl complexes with tridentate chelators for myocardium imaging
08/07/2008WO2008059029A3 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate
08/07/2008WO2008058098A3 Method of treating asthma, allergic rhinitis, and skin disorders
08/07/2008WO2008058096A3 Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
08/07/2008WO2008057604A3 Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
08/07/2008WO2008054808A3 Elvucitabine pharmaceutical compositions
08/07/2008WO2008054748A3 Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/07/2008WO2008054639A3 Use of a catechin or polyphenol to treat ocular diseases and infection
08/07/2008WO2008053301A3 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
08/07/2008WO2008051525A3 Methods of treating ovarian cancer
08/07/2008WO2008042240A9 Enantiomerically pure phosphoindoles as hiv inhibitors
08/07/2008WO2008039937A3 Blocking of gene expression in eukaryotic cells
08/07/2008WO2008039538A3 Compositions of tlr ligands and antivirals
08/07/2008WO2008036858A3 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
08/07/2008WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/07/2008WO2008035177A3 Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor
08/07/2008WO2008034912A3 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
08/07/2008WO2008034580A3 Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases
08/07/2008WO2008034124A3 Targeted polymeric prodrugs containing multifunctional linkers
08/07/2008WO2008033999A3 Kinase inhibitors useful for the treatment of proliferative diseases
08/07/2008WO2008033449A3 Compounds for the treatment of angiogenesis
08/07/2008WO2008031440A3 Isoniazid mediated healing of wounds and ulcers
08/07/2008WO2008027855A3 Compositions and methods for modulating mtor signaling
08/07/2008WO2008026915A3 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
08/07/2008WO2008024006A3 Pharmaceutical preparation in a gel form
08/07/2008WO2008009655B1 Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds
08/07/2008WO2008008153A3 Bird feeder
08/07/2008WO2007145704A3 Gemcitabine combination therapy
08/07/2008WO2007140222A3 Pyrrolopyrimidine compounds and their uses
08/07/2008WO2007137181A3 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
08/07/2008WO2007131232A3 Compositions and their uses directed to ptpr alpha
08/07/2008WO2007126935A3 Diazepan orexin receptor antagonists
08/07/2008WO2007124498A3 Method for treating malignancies of hematopoietic lineage
08/07/2008WO2007121479A3 Methods and compositions for treating barth syndrome, cardiomyopathy, mitochondrial diseases and other conditions
08/07/2008WO2007120936A3 Use.of vildagliptin for the treatment of diabetes
08/07/2008WO2007120709A3 Methods and compositions for treatment of lesioned sites of body vessels
08/07/2008WO2007111948A3 Inhibitors of protein prenyltransferases
08/07/2008WO2007098118A3 Antineoplastic and curcumin derivatives and methods of preparation and use
08/07/2008WO2007092899A3 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus
08/07/2008WO2007091947A8 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
08/07/2008WO2007076322A8 Compositions and methods for attenuating mitochondria-mediated cell injury
08/07/2008WO2007069274A3 Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
08/07/2008WO2007068116A8 Method for correcting a lipid imbalance in a subject
08/07/2008WO2007062145A3 Chemical compounds
08/07/2008WO2006133128A3 INHIBITION OF EPAC, PHOSPHOLIPASE Cϵ, AND PHOSPHOLIPASE D TO TREAT PAIN
08/07/2008US20080188669 Novel mixture and compounds from mycelia of Antrodia camphorata and use thereof
08/07/2008US20080188646 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy) heptanoic acid, preparation process for the same and dauer effect thereof
08/07/2008US20080188570 Therapeutic compounds
08/07/2008US20080188569 Cosmetic
08/07/2008US20080188568 Stabilizing positively charged active ingredient inside beads; penetration; shelf life
08/07/2008US20080188567 Crystalline polymorphs of desvenlafaxine succinate and their preparations
08/07/2008US20080188566 Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
08/07/2008US20080188565 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
08/07/2008US20080188564 Insecticidal and Nematicidal Compositions and Methods of Use
08/07/2008US20080188563 Blood fluidity improving agent
08/07/2008US20080188562 Treating tinnitus using prodrugs of gabapentin and pregabalin
08/07/2008US20080188561 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
08/07/2008US20080188560 Cosmetic Compositions and Methods For Sensory Cooling
08/07/2008US20080188559 Modified Retinoid Compounds and Their Uses
08/07/2008US20080188558 Esters such as benzyl, 4-nitrobenzyl and/or 4-chlorobenzyl administered to the skin as photosensitizers; photoactivating; treating acne vulgaris, acne rosacea, acne conglobate, acne papulosa and premenstrual acne; acne associated with Propionibacteriums; cosmetics
08/07/2008US20080188557 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
08/07/2008US20080188556 Nitrogen-containing esters of the secondary alcohol group of florfenicol and of its analogs,including salts; veterinary medicine; nonhydrolyzing as needed to maintain the prodrug in aqueous solution in the subjects system until appropriate; cattle drinking water; bovine respiratory disease
08/07/2008US20080188555 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
08/07/2008US20080188554 Isolated nucleic acids; soluble epoxide hydrolase inhibitors; right sided congestive heart failure, hypoxemia
08/07/2008US20080188553 Derivatives with lysine and proline moieties; topical skin damage ointments; antioxidant and free radical scavenging activity
08/07/2008US20080188552 Crystalline form of sodium pravastatin produced from amine salt; high purity and yield; antihypercholesterolemic agents; low raw material cost
08/07/2008US20080188551 Cosmetic Composition Comprising A Lipid Fraction From Vegetal Source And Anticrystaling Agent
08/07/2008US20080188550 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
08/07/2008US20080188549 A specific edible compound derived from a naturally occurring substance such as licorice; a peroxisome proliferator activated receptors gamma ligand agent; flavonoids; anticholesterol agents;antilipemic agents; hypoglycemic agents; antidiabetic agents
08/07/2008US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof
08/07/2008US20080188547 Uses of ion channel modulating compounds
1 ... 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 ... 7860